Loading...
Veltuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD20 receptors, Veltuzumab is a monoclonal antibody which, as of October 2009, is undergoing Phase I/II clinical trials for the treatment of non-Hodgkin's lymphoma.
Biosimilars
Human
Monoclonal
Human
CD20 receptors
Human
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 728917-18-8
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más